Dopamine D2 receptor suppresses gastric cancer cell invasion and migration via inhibition of EGFR/AKT/MMP-13 pathway.
Huang, Hongli
Dopamine D2 receptor suppresses gastric cancer cell invasion and migration via inhibition of EGFR/AKT/MMP-13 pathway. [electronic resource] - International immunopharmacology Oct 2016 - 113-120 p. digital
Publication Type: Journal Article
1878-1705
10.1016/j.intimp.2016.07.002 doi
Antineoplastic Agents--therapeutic use
Carcinogenesis--drug effects
Cell Line, Tumor
Cell Movement--drug effects
Cell Proliferation--drug effects
Dopamine--therapeutic use
Epidermal Growth Factor--metabolism
ErbB Receptors--metabolism
Gene Expression Regulation, Neoplastic--drug effects
Humans
Matrix Metalloproteinase 13--metabolism
Oncogene Protein v-akt--metabolism
Receptors, Dopamine D2--agonists
Signal Transduction--drug effects
Stomach Neoplasms--drug therapy
Dopamine D2 receptor suppresses gastric cancer cell invasion and migration via inhibition of EGFR/AKT/MMP-13 pathway. [electronic resource] - International immunopharmacology Oct 2016 - 113-120 p. digital
Publication Type: Journal Article
1878-1705
10.1016/j.intimp.2016.07.002 doi
Antineoplastic Agents--therapeutic use
Carcinogenesis--drug effects
Cell Line, Tumor
Cell Movement--drug effects
Cell Proliferation--drug effects
Dopamine--therapeutic use
Epidermal Growth Factor--metabolism
ErbB Receptors--metabolism
Gene Expression Regulation, Neoplastic--drug effects
Humans
Matrix Metalloproteinase 13--metabolism
Oncogene Protein v-akt--metabolism
Receptors, Dopamine D2--agonists
Signal Transduction--drug effects
Stomach Neoplasms--drug therapy